OPTN - רווח נקי למניה (EPS TTM) OptiNose Inc

OptiNose, Inc. (OPTN) is expanding its reach among sinusitis patients through effective drug delivery. High development costs for sprayers and patent protection create a significant barrier to entry for competitors. The growth in XHANCE prescriptions is bringing the company closer to profitability. The rolling earnings per share trend demonstrates the dynamics of this process, and the value of -3.00 reflects the metric's balance.

OptiNose, Inc. (OPTN) is expanding the distribution of its nasal spray through strategic partnerships with retail chains. This indicator reflects the net profit per common share over the last twelve months. A positive trend indicates the efficiency of the operating model and an increase in the real value of capital. It is critical for investors to compare current values with the historical average to assess business sustainability. The price action of net profit per share allows for the timely identification of an overbought asset.